International Precision Medicine Conference
March 13-15, 2025
Companion Diagnostics in Precision Medicine
Companion diagnostic tests identify specific genetic mutations and biomarkers in individuals who are most likely to benefit from precision medicine treatment, lowering the number of patients who are treated. Companion diagnostics play a pivotal role in the development of targeted medications, and their effectiveness determines the success of this type of therapy to a great extent. Companion diagnostic assays use a single patient as a reference point and will be crucial in the transition to more precise and personalized medication. These are medical gadgets that assist doctors in determining the treatments and dosages to offer patients, based on the patient's individual needs. The companion diagnostic is necessary for the drug's safe and effective use.
- FDA approval
- Companion diagnostic genetic test
Roy Gary Beran
University of New South Wales, Australia
Ewa Danuta Bialek
Institute of Psychosynthesis, Poland
Sergey Suchkov
The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Jinyuan Zhou
Johns Hopkins University School of Medicine, United States
Wei Wu
UCSF, United States
Xu Chen
The College of St. Scholastica, United States
Styliani Geronikolou
University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Pharmacotherapy in the Treatment of Epilepsy - Use of Antiseizure Medications and Therapeutic Blood Level Monitoring
Roy Gary Beran, University of New South Wales, Australia
Title : When something comes on time, it is education, if too late, it is therapy. Health or disease - It is our choice
Ewa Danuta Bialek, Institute of Psychosynthesis, Poland
Title : Antibody-Proteases as translational tools of the newest generation to be applied for biodesign and bioengineering to get Precision and Personalized healthcare services Re-armed
Sergey Suchkov, The Russian University of Medicine & Russian Academy of Natural Sciences, Russian Federation
Title : Exposome for precision medicine
Styliani Geronikolou, University Research Institute of Maternal and Child health & Precision Medicine, Greece
Title : Precision Diagnostics and Medical Devices: Innovative Imaging Technologies for Lung Cancer Screening in Large Populations
Huiqin Yang, ICON Clinical Research Ltd, United Kingdom
Title : Use of indocyanine green fluorescence imaging in the extrahepatic biliary tract surgery
Orestis Ioannidis, Aristotle University of Thessaloniki, Greece